Abstract
Purpose
Non-steroidal anti-inflammatory drugs (NSAIDs) are not recommended in the 3rd trimester of pregnancy due to known fetal adverse effects in an advanced gestational age. This investigation was performed to assess whether there is a significant risk of NSAIDs being used as an analgesic or antipyretic medication in the 2nd trimester.
Methods
A systematic search for publications reporting 2nd trimester NSAID exposure was performed in MEDLINE. The search focused on case descriptions reporting defined adverse effects including prenatal ductus arteriosus constriction, oligohydramnios, neonatal renal failure, and primary pulmonary hypertension. Original articles published until February 2018 were considered for evaluation.
Results
Out of 681 identified publications, 26 included relevant information on the defined adverse effects. Among these publications, premature labor was the major reason for 2nd trimester indomethacin treatment while other clinical indications and other NSAIDs were underrepresented. Narrowing or closure of the ductus arteriosus in the 2nd trimester was described in 33 fetuses. Only eight publications reported adverse effects after less than 7-day exposure during the 2nd trimester.
Conclusions
Based on these results, short-term use of NSAIDs as analgesics or antipyretics in the 2nd trimester does not appear to pose a substantial risk for fetal adverse effects. Long-term use in the late 2nd trimester, however, should always be monitored.
Similar content being viewed by others
References
Moise KJ Jr (1993) Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use. Am J Obstet Gynecol 168(5):1350–1353
Karadeniz C, Ozdemir R, Kurtulmus S, Doksoz O, Yozgat Y, Mese T (2013) Diclofenac-induced intrauterine ductal closure. Fetal Diagn Ther 34(2):133–134. https://doi.org/10.1159/000350979
Rein AJ, Nadjari M, Elchalal U, Nir A (1999) Contraction of the fetal ductus arteriosus induced by diclofenac. Case report Fetal Diagn Ther 14(1):24–25. https://doi.org/10.1159/000020882
Torloni MR, Cordioli E, Zamith MM, Hisaba WJ, Nardozza LM, Santana RM, Moron AF (2006) Reversible constriction of the fetal ductus arteriosus after maternal use of topical diclofenac and methyl salicylate. Ultrasound Obstet Gynecol 27(2):227–229
Holmes RP, Stone PR (2000) Severe oligohydramnios induced by cyclooxygenase-2 inhibitor nimesulide. Obstet Gynecol 96(5 Pt 2):810–811
Lopes LM, Carrilho MC, Francisco RP, Lopes MA, Krebs VL, Zugaib M (2016) Fetal ductus arteriosus constriction and closure: analysis of the causes and perinatal outcome related to 45 consecutive cases. J Matern Fetal Neonatal Med 29(4):638–645. https://doi.org/10.3109/14767058.14762015.11015413
Luchese S, Manica JL, Zielinsky P (2003) Intrauterine ductus arteriosus constriction: analysis of a historic cohort of 20 cases. Arq Bras Cardiol 81(4):405–410
Savage AH, Anderson BL, Simhan HN (2007) The safety of prolonged indomethacin therapy. Am J Perinatol 24(4):207–213
Scherneck S, Schopa FL, Entezami M, Kayser A, Weber-Schoendorfer C, Schaefer C (2015) Reversible oligohydramnios in the second trimester of pregnancy in two patients with long-term diclofenac exposure. Reprod Toxicol 58:61–64. https://doi.org/10.1016/jreprotox201510081002
Shehata BM, Bare JB, Denton TD, Habib MN, Black JO (2006) Premature closure of the ductus arteriosus: variable response among monozygotic twins after in utero exposure to indomethacin. Fetal Pediatr Pathol 25(3):151–157
Tarcan A, Gurakan B, Yildirim S, Ozkiraz S, Bilezikci B (2004) Persistent pulmonary hypertension in a premature newborn after 16 hours of antenatal indomethacin exposure. J Perinat Med 32(1):98–99
Voyer LE, Drut R, Mendez JH (1994) Fetal renal maldevelopment with oligohydramnios following maternal use of piroxicam. Pediatr Nephrol 8(5):592–594
Baker ER, Eberhardt H, Brown ZA (1993) "Stuck twin" syndrome associated with congenital cytomegalovirus infection. Am J Perinatol 10(1):81–83
Gouyon JB, Petion AM, Sandre D, Sgro C, Bavoux F (1991) Neonatal kidney insufficiency and intrauterine exposure to ketoprofen. Arch Fr Pediatr 48(5):347–348
Llanas B, Cavert MH, Apere H, Demarquez JL (1996) Adverse effects of ketoprofen after intrauterine exposure. Value of plasma determination. Arch Pediatr 3(3):248–253
Bivins HA Jr, Newman RB, Fyfe DA, Campbell BA, Stramm SL (1993) Randomized trial of oral indomethacin and terbutaline sulfate for the long-term suppression of preterm labor. Am J Obstet Gynecol 169(4):1065–1070
Buderus S, Thomas B, Fahnenstich H, Kowalewski S (1993) Renal failure in two preterm infants: toxic effect of prenatal maternal indomethacin treatment? Br J Obstet Gynaecol 100(1):97–98
Harada K, Rice MJ, Shiota T, McDonald RW, Reller MD, Sahn DJ (1997) Two-dimensional echocardiographic evaluation of ventricular systolic function in human fetuses with ductal constriction. Ultrasound Obstet Gynecol 10(4):247–253
Kirshon B, Moise KJ Jr, Mari G, Willis R (1991) Long-term indomethacin therapy decreases fetal urine output and results in oligohydramnios. Am J Perinatol 8(2):86–88
Levy R, Matitiau A, Ben Arie A, Milman D, Or Y, Hagay Z (1999) Indomethacin and corticosteroids: an additive constrictive effect on the fetal ductus arteriosus. Am J Perinatol 16(8):379–383
Moise KJ Jr, Huhta JC, Sharif DS, Ou CN, Kirshon B, Wasserstrum N, Cano L (1988) Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. N Engl J Med 319(6):327–331
Pratt L, Digiosia J, Swenson JN, Trampe B, Martin CB Jr (1997) Reversible fetal hydrops associated with indomethacin use. Obstet Gynecol 90(4 Pt 2):676–678
Respondek M, Weil SR, Huhta JC (1995) Fetal echocardiography during indomethacin treatment. Ultrasound Obstet Gynecol 5(2):86–89
Truter PJ, Franszen S, van der Merwe JV, Coetzee MJ (1986) Premature closure of the ductus arteriosus causing intra-uterine death. A case report. S Afr Med J 70(9):557–558
Van den Veyver IB, Moise KJ Jr, Ou CN, Carpenter RJ Jr (1993) The effect of gestational age and fetal indomethacin levels on the incidence of constriction of the fetal ductus arteriosus. Obstet Gynecol 82(4 Pt 1):500–503
Vermillion ST, Scardo JA, Lashus AG, Wiles HB (1997) The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol 177(2):256–259
Hickok DE, Hollenbach KA, Reilley SF, Nyberg DA (1989) The association between decreased amniotic fluid volume and treatment with nonsteroidal anti-inflammatory agents for preterm labor. Am J Obstet Gynecol 160(6):1525–1530
Jacqz-Aigrain E, Guillonneau M, Boissinot C, Bavoux F, Hartmann JF, Blot P (1993) Maternal and neonatal effects of indomethacin administrated during pregnancy. Apropos of 18 cases. Arch Fr Pediatr 50(4):307–312
Nishikubo T, Takahashi Y, Nakagawa Y, Kawaguchi C, Nakajima M, Ichijo M, Yoshioka A (1994) Renal impairment in very low birthweight infants following antenatal indomethacin administration. Acta Paediatr Jpn 36(2):202–206
World Health Organization (2015) WHO guidelines approved by the guidelines review committee. WHO recommendations on interventions to improve preterm birth outcomes
Pham JT, Carlos MA (2002) Current treatment strategies of symptomatic patent ductus arteriosus. J Pediatr Health Care 16(6):306–310
Rostas SE, McPherson CC (2016) Pharmacotherapy for patent ductus arteriosus: current options and outstanding questions. Curr Pediatr Rev 12(2):110–119
Mitra S, Florez ID, Tamayo ME, Mbuagbaw L, Vanniyasingam T, Veroniki AA, Zea AM, Zhang Y, Sadeghirad B, Thabane L (2018) Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. JAMA 319(12):1221–1238. https://doi.org/10.1001/jama.2018.1896
Ohlsson A, Shah PS (2018) Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs. Cochrane Database Syst Rev 4:CD010061. https://doi.org/10.1002/14651858.CD010061.pub3
Ohlsson A, Walia R, Shah SS (2018) Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev 9:CD003481. https://doi.org/10.1002/14651858.CD003481.pub7
Eronen M (1993) The hemodynamic effects of antenatal indomethacin and a beta-sympathomimetic agent on the fetus and the newborn: a randomized study. Pediatr Res 33(6):615–619
Momma K, Hagiwara H, Konishi T (1984) Indomethacin for preterm labor: a randomized comparison of vaginal and rectal-oral routes. Prostaglandins 28(4):527–536
Momma K, Takeuchi H (1983) Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs: study of additional 34 drugs. Prostaglandins 26(4):631–643
Leal SD, Cavalle-Garrido T, Ryan G, Farine D, Heilbut M, Smallhorn JF (1997) Isolated ductal closure in utero diagnosed by fetal echocardiography. Am J Perinatol 14(4):205–210
Marti Sole JJ, Pasarisas Sala M (1996) A possible association between the maternal administration of metamizole and persistent pulmonary hypertension in a newborn infant. An Esp Pediatr 44(4):387–388
Wilkinson AR, Aynsley-Green A, Mitchell MD (1979) Persistent pulmonary hypertension and abnormal prostaglandin E levels in preterm infants after maternal treatment with naproxen. Arch Dis Child 54(12):942–945
Van Marter LJ, Leviton A, Allred EN, Pagano M, Sullivan KF, Cohen A, Epstein MF (1996) Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. Pediatrics 97(5):658–663
Abramov Y, Nadjari M, Weinstein D, Ben-Shachar I, Plotkin V, Ezra Y (2000) Indomethacin for preterm labor: a randomized comparison of vaginal and rectal-oral routes. Obstet Gynecol 95(4):482–486
Dutta EH, Behnia F, Harirah H, Costantine M, Saade G (2016) Perinatal outcomes after short versus prolonged indomethacin for tocolysis in women with preterm labor. Am J Perinatol 33(9):844–848. https://doi.org/10.1055/s-0036-1579647
Gardner MO, Owen J, Skelly S, Hauth JC (1996) Preterm delivery after indomethacin. A risk factor for neonatal complications? J Reprod Med 41(12):903–906
Hendricks SK, Smith JR, Moore DE, Brown ZA (1990) Oligohydramnios associated with prostaglandin synthetase inhibitors in preterm labour. Br J Obstet Gynaecol 97(4):312–316
Uslu T, Ozcan FS, Aydin C (1992) Oligohydramnios induced by maternal indomethacin therapy. Int J Clin Pharmacol Ther Toxicol 30(7):230–232
van der Heijden BJ, Carlus C, Narcy F, Bavoux F, Delezoide AL, Gubler MC (1994) Persistent anuria, neonatal death, and renal microcystic lesions after prenatal exposure to indomethacin. Am J Obstet Gynecol 171(3):617–623
Acknowledgments
We thank Luisa Maria Köhler and Verena Linsenmeier who helped to obtain the required full-text publications. Part of the literature review will be included in the thesis of Lucas William Pritchard.
Funding
This work was funded by the German Federal Institute for Drugs and Medical Devices (BfArM).
Author information
Authors and Affiliations
Contributions
KD and CS developed the approach. KD and LWP developed the search strategy and conducted the literature search. KD, LWP, and SH screened the articles. KD and SH extracted the data from the relevant literature and created the evidence tables. All the listed authors participated in the result interpretation. KD and CS wrote the first draft of the manuscript, and all authors critically revised subsequent manuscript drafts and contributed essential discussion points. LWP edited the manuscript. All the listed authors approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Dathe, K., Hultzsch, S., Pritchard, L.W. et al. Risk estimation of fetal adverse effects after short-term second trimester exposure to non-steroidal anti-inflammatory drugs: a literature review. Eur J Clin Pharmacol 75, 1347–1353 (2019). https://doi.org/10.1007/s00228-019-02712-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-019-02712-2